Dr. Agarwal's Health Care Limited logo

AGARWALEYE

NSE
Dr. Agarwal's Health Care Limited (SMALL CAP)
Healthcare>Healthcare>Healthcare Services>Hospital
439.75
0.35 (0.08%)
High VOLATILITY
As on 12 Jun 2026

Price History

Market Cap
₹13.93K Cr
SMALL CAP
P/E Ratio
82.8
Industry
Hospital
52-Week Range
52W Low362.5+21.3%
52W High568-22.6%
Current Price
439.75
Circuit Limits (20%)
Lower Circuit351.80
Upper Circuit527.70
Reference Price
439.75

Investment Checklist

Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹408.1
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹422.5
Trend: Price below most MAs — downtrend
News: Dr. Agarwal's Shares May Rally 35% on Strong Surgical Growth, Says Motilal Oswal...
10/20 Bearish Cross detected 2 day(s) ago

Technical Analysis

Technical Analysis

Analysis from 2026-06-12

Confidence
42%

Trend

BEARISH
BEARISH

Price below most MAs — downtrend

EMA20
457.44
EMA50
454
EMA200
454.82

Price Action

DOWNTREND
BEARISH
Higher Highs2
Higher Lows2
Lower Highs7
Lower Lows7

Support & Resistance Levels

Resistance (Above)
461.35
472.40
485.12
493.90
513.80
Support (Below)
437.90
420.52
412.23
401.00

Volume Analysis

TrendDECREASING
Change-47.30%
Unusual VolumeNo

Recent MA Crossovers

10/20 Bearish Cross
2 days ago
SELL

Recent Price Gaps

Gap Down
5 days ago • 0.04%
BEARISH

Stop Loss Levels

Fixed Risk

1% Risk435.35
3% Risk426.56
5% Risk417.76
7% Risk (Custom)
408.97

Technical Levels

1x ATR (Volatility)425.59
2x ATR (Swing)411.43
3x ATR (Trend)397.27
Immediate Support437.90

Financials

Financial Analysis

MetricMar '25Jun '25Sep '25Dec '25
Revenue₹453.8 Cr₹487.4 Cr₹529.9 Cr
Net Profit₹32.6 Cr₹30.1 Cr₹33.7 Cr
EPS₹0.95₹1.07
Operating Profit₹142.5 Cr₹141.3 Cr₹154.6 Cr

Peer Comparison

Hospital

Peer Comparison

SymbolNamePriceChange
APOLLOHOSPApollo Hospitals Enterprise Limited₹8,498.00+0.06%
MAXHEALTHMax Healthcare Institute Limited₹1,012.45+0.28%
FORTISFortis Healthcare Limited₹990.35+0.14%
ASTERDMAster DM Healthcare Limited₹814.95+0.15%
NHNarayana Hrudayalaya Ltd.₹1,893.90+1.90%
MEDANTAGlobal Health Limited₹1,235.10+0.49%
KIMSKrishna Institute of Medical Sciences Limited₹785.10+2.57%
RAINBOWRainbow Childrens Medicare Limited₹1,365.00+1.87%
PARKHOSPSPark Medi World Limited₹274.60+0.49%
HCGHealthcare Global Enterprises Limited₹630.50+0.17%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Announcements

Latest updates

View All
DateDescriptionLink
02 Jun 2026
Copy of Newspaper Publication
01 Jun 2026
General Updates
01 Jun 2026
Amalgamation/Merger
01 Jun 2026
Amalgamation/Merger
01 Jun 2026
Shareholders meeting

Board Meetings

Upcoming and past meetings

View All
DatePurposeLinks
21 May 2026
Financial Results
21 May 2026
Board Meeting Intimation
03 Feb 2026
Board Meeting Intimation
03 Feb 2026
Financial Results
30 Oct 2025
Board Meeting Intimation

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 4 Qtrs)

Latest News

News for AGARWALEYE

View All
Dr. Agarwal's Shares May Rally 35% on Strong Surgical Growth, Says Motilal Oswal — Check Target Price
positive
NDTV Profit 4d ago

Dr. Agarwal's Shares May Rally 35% on Strong Surgical Growth, Says Motilal Oswal — Check Target Price

Motilal Oswal remains bullish on Dr. Agarwal's structural growth story, backed by its leadership in the eye-care segment and a rapidly scaling surgical franchise.

AGARWALEYEMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUENRAILFinancial ServicesForest Materials
Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore
positive
ET Markets - Industry 4d ago

Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore

Viyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion animal health business. BioForLife offers a strong presence in the Italian pet care market. The acquisition is expected to finalize in the second quarter of FY 2026-27.

AGARWALEYEAMRUTANJANGLOBALGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsConsumer Services
NEWS
positive
Business Standard - Markets 5d ago

Viyash Scientific to acquire Milan-based pet care company BioForLife

Viyash Scientific (Viyash), through its wholly owned subsidiary Alivira Animal Health (Alivira), has signed a binding agreement to acquire 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy. The acquisition, for a cash consideration of Rs 188 crore is expected to close in Q2 FY27.

AGARWALEYEAMRUTANJANGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsFast Moving Consumer Goods

Frequently Asked Questions